Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 26-50 of 98 citing articles:

Microbiota-Mitochondria Inter-Talk: A Potential Therapeutic Strategy in Obesity and Type 2 Diabetes
Teresa Vezza, Zaida Abad‐Jiménez, Miguel Martı́-Cabrera, et al.
Antioxidants (2020) Vol. 9, Iss. 9, pp. 848-848
Open Access | Times Cited: 42
Regulation of Vascular Function and Inflammation via Cross Talk of Reactive Oxygen and Nitrogen Species from Mitochondria or NADPH Oxidase—Implications for Diabetes Progression
Andreas Daiber, Sebastian Steven, Ksenija Vujačić-Mirski, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3405-3405
Open Access | Times Cited: 41
Adipose-derived stem cells alleviate liver injury induced by type 1 diabetes mellitus by inhibiting mitochondrial stress and attenuating inflammation
Yanli Hou, Wenyu Ding, Peishan Wu, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Cardiovascular disease treatment using traditional Chinese medicine：Mitochondria as the Achilles' heel
Jie Gao, Tianshu Hou
Biomedicine & Pharmacotherapy (2023) Vol. 164, pp. 114999-114999
Open Access | Times Cited: 15
Role of sirtuin 1 in depression‑induced coronary heart disease: Molecular pathways and therapeutic potential (Review)
Shijie Zheng, Linlin Yang, Qiuting Dai, et al.
Biomedical Reports (2025) Vol. 22, Iss. 3
Open Access
Antioxidant and Anti-Inflammatory Activities of Buffalo Milk δ-Valerobetaine
Nunzia D’Onofrio, Anna Balestrieri, Gianluca Neglia, et al.
Journal of Agricultural and Food Chemistry (2019) Vol. 67, Iss. 6, pp. 1702-1710
Closed Access | Times Cited: 35
Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
Tan Zhang, Shuzhe Ding, Ru Wang
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10866-10866
Open Access | Times Cited: 30
NLRP3 inflammasome links vascular senescence to diabetic vascular lesions
Guang-Jie Tai, Qingqing Yu, Jiapeng Li, et al.
Pharmacological Research (2022) Vol. 178, pp. 106143-106143
Open Access | Times Cited: 19
Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
Yifei Chen, Fuji Yang, Ying Chu, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 19
Targeting the PINK1/Parkin Pathway: a new perspective in the prevention and therapy of diabetic retinopathy
Agata Grazia D’Amico, Grazia Maugeri, Benedetta Magrì, et al.
Experimental Eye Research (2024) Vol. 247, pp. 110024-110024
Closed Access | Times Cited: 4
Tetrandrine alleviates cerebral ischemia/reperfusion injury by suppressing NLRP3 inflammasome activation via Sirt-1
Jun Wang, Ming Guo, Ruojia Ma, et al.
PeerJ (2020) Vol. 8, pp. e9042-e9042
Open Access | Times Cited: 28
Activation of NLRP3 inflammasome in hepatocytes after exposure to cobalt nanoparticles: The role of oxidative stress
Sisi Feng, Zhenyu Zhang, Yiqing Mo, et al.
Toxicology in Vitro (2020) Vol. 69, pp. 104967-104967
Closed Access | Times Cited: 28
The effect of tai chi intervention on NLRP3 and its related antiviral inflammatory factors in the serum of patients with pre-diabetes
Shujuan Hu, Yingxing Hu, Peilin Long, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Nerolidol rescues hippocampal injury of diabetic rats through inhibiting NLRP3 inflammasome and regulation of MAPK/AKT pathway
Yining Lei, Manqin Li, Xinran Liu, et al.
BioFactors (2024)
Closed Access | Times Cited: 3
Pharmacological insights and role of bufalin (bufadienolides) in inflammation modulation: a narrative review
Gagandeep Kaur, Sushma Devi, Akhil Sharma, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 5, pp. 3057-3077
Closed Access | Times Cited: 3
MCC950 as a promising candidate for blocking NLRP3 inflammasome activation: A review of preclinical research and future directions
Yujia Zheng, Xiaolu Zhang, Ziyu Wang, et al.
Archiv der Pharmazie (2024) Vol. 357, Iss. 11
Closed Access | Times Cited: 3
Elamipretide Attenuates Pyroptosis and Perioperative Neurocognitive Disorders in Aged Mice
Youmei Zuo, Lei Yin, Xinqi Cheng, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 26
Paeonol for the Treatment of Atherosclerotic Cardiovascular Disease: A Pharmacological and Mechanistic Overview
Min Wu, Zongliang Yu, Xiaoya Li, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 23
VDAC1 regulates mitophagy in NLRP3 inflammasome activation in retinal capillary endothelial cells under high-glucose conditions
Jie Xie, Ying Cui, Xiangting Chen, et al.
Experimental Eye Research (2021) Vol. 209, pp. 108640-108640
Closed Access | Times Cited: 22
NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically
Ainara González-Moro, Inés Valencia, Licia Shamoon, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 269-269
Open Access | Times Cited: 14
Insights into the Role of Plasmatic and Exosomal microRNAs in Oxidative Stress-Related Metabolic Diseases
Ayauly Duisenbek, Gabriela del Carmen López-Armas, Miguel Pérez‐Milans, et al.
Antioxidants (2023) Vol. 12, Iss. 6, pp. 1290-1290
Open Access | Times Cited: 8
Does Glycemic Control Modulate the Impairment of NLRP3 Inflammasome Activation in Type 2 Diabetes?
Francesca Iannantuoni, Noelia Díaz‐Morales, Irene Escribano‐López, et al.
Antioxidants and Redox Signaling (2018) Vol. 30, Iss. 2, pp. 232-240
Closed Access | Times Cited: 24
A novel mechanism for NLRP3 inflammasome activation
Tan Zhang, Jingyao Zhao, Tiemin Liu, et al.
Metabolism Open (2022) Vol. 13, pp. 100166-100166
Open Access | Times Cited: 13
Aerobic exercise alleviates pyroptosis-related diseases by regulating NLRP3 inflammasome
Shujuan Hu, Xingxia Wan, Xianhui Li, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 13
Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
Sourav De, Yung‐Chih Kuo
Journal of the Taiwan Institute of Chemical Engineers (2024) Vol. 157, pp. 105401-105401
Closed Access | Times Cited: 2

Scroll to top